The Company and Nature of Business (Details)			1 Months Ended	6 Months Ended
	Feb. 12, 2018 shares	Nov. 10, 2010 shares	Jan. 26, 2021 shares	Jun. 30, 2021 shares	Jun. 04, 2021 shares
The Company and Nature of Business (Details) [Line Items]
Common stock shares issued			35,316,768
Common stock outstanding percentage			80.00%
Series C convertible preferred stock					101,015,049
RSU [Member]
The Company and Nature of Business (Details) [Line Items]
Exercisable shares of common stock			6,070,842
Agreement and Plan of Merger [Member] | Boston Therapeutics, Inc. [Member]
The Company and Nature of Business (Details) [Line Items]
Common stock shares issued		4,000,000
Common stock outstanding percentage		100.00%
Contribution Agreement [Member] | CureDM Group Holdings, LLC [Member]
The Company and Nature of Business (Details) [Line Items]
Common stock shares issued	47,741,140
Number of shares issued at time of delivered	25,000,000
Number of shares issued at time of milestones	22,741,140
Number of tranches for delivered | Tranches	4
Number of shares issued per tranches	5,685,285
Common Stock [Member]
The Company and Nature of Business (Details) [Line Items]
Common stock shares issued				813,125
Exercisable shares of common stock			2,100,911
Series C Convertible Preferred Stock [Member]
The Company and Nature of Business (Details) [Line Items]
Series C convertible preferred stock			1,000,000